View of Rosuvastatin Monotherapy Versus Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity, Vascular Inflammation, and Lipid Profile In Patients With Type 2 Diabetes Mellitus: A Randomised Controlled Trial

Return to Article Details Rosuvastatin Monotherapy Versus Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity, Vascular Inflammation, and Lipid Profile In Patients With Type 2 Diabetes Mellitus: A Randomised Controlled Trial Download Download PDF